SkyePharma seeks new capital for bond buyback
SkyePharma, the UK pharmaceutical company, is set to issue up to 58.7m shares through an open offer, raising capital to finance the buyback of its outstanding bond paper.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts